Immunocore Holdings plc Quarterly Debt-to-equity in % from Q3 2024 to Q1 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Immunocore Holdings plc quarterly Debt-to-equity history and growth rate from Q3 2024 to Q1 2025.
  • Immunocore Holdings plc Debt-to-equity for the quarter ending March 31, 2025 was 181 %.
Debt-to-equity, Quarterly (%)
Period Value YoY Chg Change % Date
Q1 2025 181 Mar 31, 2025
Q4 2024 182 Dec 31, 2024
Q3 2024 152 Sep 30, 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.